Advertisement
Screener

Puramed Bioscience Inc. Stock-Based Compensation

Puramed Bioscience Inc. Stock-Based Compensation

Puramed Bioscience Inc. reported Stock-Based Compensation of $1.08 million for the 12-month period ending 2014-06-30, per its 10-K filed 2014-10-14.

Discontinued › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2014-10-14

  • Puramed Bioscience Inc. share-based payment arrangement, noncash expense for fiscal 2014 was $1.08M.
  • Puramed Bioscience Inc. share-based payment arrangement, noncash expense for fiscal 2013 was $0.00.
Period endShare-based Payment Arrangement, Noncash Expense 12 month
2014-06-30$1.08M
10-K · filed 2014-10-14
2013-06-30$0.00
10-K · filed 2014-10-14